ASCEND: A Study of Cardiovascular Events iN Diabetes

PHASE4Active, not recruitingINTERVENTIONAL
Enrollment

15,480

Participants

Timeline

Start Date

March 31, 2005

Primary Completion Date

March 12, 2018

Study Completion Date

July 31, 2037

Conditions
Diabetes Mellitus
Interventions
DRUG

Aspirin

DRUG

Omega-3 Ethyl Esters

DRUG

Placebo Aspirin

DRUG

Placebo Omega-3 Ethyl Esters

Trial Locations (1)

OX3 7LF

Clinical Trial Service Unit, NDPH, University of Oxford, Oxford

All Listed Sponsors
collaborator

British Heart Foundation

OTHER

collaborator

Bayer

INDUSTRY

collaborator

Medical Research Council

OTHER_GOV

collaborator

Solvay Pharmaceuticals

INDUSTRY

collaborator

Abbott

INDUSTRY

collaborator

Mylan

UNKNOWN

collaborator

Health Data Research UK

UNKNOWN

collaborator

Alzheimer's Research UK

UNKNOWN

collaborator

The Macular Society

UNKNOWN

lead

University of Oxford

OTHER